Sunday 27 March 2011

Keligroll




Keligroll may be available in the countries listed below.


Ingredient matches for Keligroll



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Keligroll in the following countries:


  • Japan

International Drug Name Search

Depromel




Depromel may be available in the countries listed below.


Ingredient matches for Depromel



Fluvoxamine

Fluvoxamine maleate (a derivative of Fluvoxamine) is reported as an ingredient of Depromel in the following countries:


  • Japan

International Drug Name Search

Saturday 26 March 2011

Feliximir




Feliximir may be available in the countries listed below.


Ingredient matches for Feliximir



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Feliximir in the following countries:


  • Italy

International Drug Name Search

Wednesday 23 March 2011

Diaglitab




Diaglitab may be available in the countries listed below.


Ingredient matches for Diaglitab



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Diaglitab in the following countries:


  • Chile

International Drug Name Search

Tuesday 22 March 2011

Chlorprothixene




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AF03

CAS registry number (Chemical Abstracts Service)

0000113-59-7

Chemical Formula

C18-H18-Cl-N-S

Molecular Weight

315

Therapeutic Category

Neuroleptic

Chemical Name

1-Propanamine, 3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethyl-, (Z)-

Foreign Names

  • Chlorprothixenum (Latin)
  • Chlorprothixen (German)
  • Chlorprothixène (French)
  • Clorprotixeno (Spanish)

Generic Names

  • Chlorprothixene (OS: JAN, USAN, BAN)
  • Chlorprothixène (OS: DCF)
  • Clorprotixene (OS: DCIT)
  • N 714 (IS)
  • Ro 4-0403 (IS)
  • Chlorprothixene Hydrochloride (OS: BANM)
  • Chlorprothixène (chlorhydrate de) (PH: Ph. Eur. 6)
  • Chlorprothixene Hydrochloride (PH: BP 2010, Ph. Eur. 6)
  • Chlorprothixenhydrochlorid (PH: Ph. Eur. 6)
  • Chlorprothixeni hydrochloridum (PH: Ph. Eur. 6)

Brand Names

  • Chlorprothixene Sine
    Sine Pharm, China


  • Truxal
    Lundbeck, Germany; Lundbeck, Finland; Lundbeck, Georgia; Lundbeck, Lithuania; Lundbeck, Taiwan


  • Chlorprothixen Holsten
    Holsten, Germany


  • Chlorprothixen Leciva
    Zentiva, Czech Republic; Zentiva, Slovakia


  • Chlorprothixen Spofa
    Spofa, Bulgaria


  • Chlorprothixen Zentiva
    Zentiva, Bulgaria


  • Chlorprothixen
    Zentiva, Latvia; Zentiva, Poland; Zentiva, Russian Federation


  • Chlorprothixen-neuraxpharm
    Neuraxpharm, Germany


  • Truxal
    Lundbeck, United Arab Emirates; Lundbeck, Austria; Lundbeck, Bahrain; Lundbeck, Switzerland; Lundbeck, Germany; Lundbeck, Denmark; Lundbeck, Estonia; Lundbeck, Egypt; Lundbeck, Finland; Lundbeck, Hungary; Lundbeck, Iraq; Lundbeck, Iran; Lundbeck, Iceland; Lundbeck, Jordan; Lundbeck, Kuwait; Lundbeck, Lebanon; Lundbeck, Latvia; Lundbeck, Netherlands; Lundbeck, Norway; Lundbeck, Oman; Lundbeck, Qatar; Lundbeck, Russian Federation; Lundbeck, Saudi Arabia; Lundbeck, Sudan; Lundbeck, Sweden; Lundbeck, Yemen


  • Truxaletten
    Lundbeck, Switzerland


  • Truxalettes
    Lundbeck, Luxembourg

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Doxazosin dura




Doxazosin dura may be available in the countries listed below.


Ingredient matches for Doxazosin dura



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosin dura in the following countries:


  • Germany

International Drug Name Search

Monday 21 March 2011

Rondec-TR Controlled-Release Tablets


Pronunciation: kar-bi-NOX-ah-meen/soo-doe-eh-FED-rin
Generic Name: Carbinoxamine/Pseudoephedrine
Brand Name: Examples include Coldec D and Rondec-TR


Rondec-TR Controlled-Release Tablets are used for:

Relieving congestion, sneezing, and watery eyes due to colds, flu, or hay fever.


Rondec-TR Controlled-Release Tablets are an antihistamine and decongestant combination. It works by blocking the action of histamine and reducing the symptoms of an allergic reaction. It also relieves nasal congestion by causing vasoconstriction and shrinkage of the nasal mucous membranes and promoting drainage.


Do NOT use Rondec-TR Controlled-Release Tablets if:


  • you are allergic to any ingredient in Rondec-TR Controlled-Release Tablets

  • you have severe high blood pressure, severe heart disease (coronary artery disease, ischemic heart disease), angle-closure glaucoma, or a peptic ulcer, or if you are unable to urinate due to bladder problems (urinary retention)

  • you are having an asthma attack

  • you are taking sodium oxybate (GHB), or if you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.



Before using Rondec-TR Controlled-Release Tablets:


Some medical conditions may interact with Rondec-TR Controlled-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have asthma; diabetes; heart disease; high blood pressure; increased inner eye pressure; a blockage of your stomach, intestines, or bladder; an overactive thyroid; difficulty urinating; an enlarged prostate; or seizures

Some MEDICINES MAY INTERACT with Rondec-TR Controlled-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Barbiturates (eg, phenobarbital), furazolidone, MAO inhibitors (eg, phenelzine), tricyclic antidepressants (eg, amitriptyline), or urinary alkalinizers (eg, antacids) because side effects, such as increased drowsiness, headache, high blood pressure, or elevated body temperature, may occur

  • Sodium oxybate (GHB) because side effects, such as an increase in sleep duration and drowsiness leading to unconsciousness or coma, may occur

  • Bromocriptine or droxidopa because the actions and side effects of these medicines may be increased

  • Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because effectiveness may be decreased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Rondec-TR Controlled-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Rondec-TR Controlled-Release Tablets:


Use Rondec-TR Controlled-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Rondec-TR Controlled-Release Tablets may be taken with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • Swallow Rondec-TR Controlled-Release Tablets whole. Do not crush or chew before swallowing. Some brands of Rondec-TR Controlled-Release Tablets may be broken in half before they are taken. If you have difficulty swallowing the whole tablet, ask your pharmacist if your brand may be broken in half.

  • If you miss a dose of Rondec-TR Controlled-Release Tablets and you are taking it regularly, take it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Rondec-TR Controlled-Release Tablets.



Important safety information:


  • Rondec-TR Controlled-Release Tablets may cause drowsiness, dizziness, or change in vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Rondec-TR Controlled-Release Tablets. Using Rondec-TR Controlled-Release Tablets alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • If you have trouble sleeping, ask your pharmacist or doctor about the best time of day to take Rondec-TR Controlled-Release Tablets.

  • Do not take diet or appetite control medicines while you are taking Rondec-TR Controlled-Release Tablets without checking with your doctor.

  • Rondec-TR Controlled-Release Tablets contains pseudoephedrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains pseudoephedrine. If it does or if you are uncertain, contact your doctor or pharmacist.

  • Use Rondec-TR Controlled-Release Tablets with caution in the ELDERLY because they may be more sensitive to its effects, especially sleeplessness.

  • Use Rondec-TR Controlled-Release Tablets with extreme caution in CHILDREN younger than 12 months of age. Safety and effectiveness in this age group have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Rondec-TR Controlled-Release Tablets, discuss with your doctor the benefits and risks of using Rondec-TR Controlled-Release Tablets during pregnancy. It is unknown if Rondec-TR Controlled-Release Tablets are excreted in breast milk. If you are or will be breast-feeding while you are using Rondec-TR Controlled-Release Tablets, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Rondec-TR Controlled-Release Tablets:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Appetite loss; diarrhea; dizziness; drowsiness; dry mouth, throat, or nose; headache; heartburn; nausea; nervousness; trouble sleeping; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; difficulty breathing; difficulty urinating; double vision; fast or irregular heartbeat; frequent or painful urination; hallucinations; seizures; severe headache and dizziness; severe nervousness; tremor; weakness.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Rondec-TR side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include decreased mental alertness; fast or irregular heartbeat; fever; hallucinations; nausea; seizures; sleeplessness; sweating; trouble breathing; unusual drowsiness or dizziness; tremors; vomiting.


Proper storage of Rondec-TR Controlled-Release Tablets:

Store Rondec-TR Controlled-Release Tablets at room temperature between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Keep Rondec-TR Controlled-Release Tablets out of the reach of children and away from pets.


General information:


  • If you have any questions about Rondec-TR Controlled-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.

  • Rondec-TR Controlled-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rondec-TR Controlled-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rondec-TR resources


  • Rondec-TR Side Effects (in more detail)
  • Rondec-TR Use in Pregnancy & Breastfeeding
  • Rondec-TR Drug Interactions
  • Rondec-TR Support Group
  • 0 Reviews for Rondec-TR - Add your own review/rating


Compare Rondec-TR with other medications


  • Cold Symptoms
  • Hay Fever

Sunday 20 March 2011

Cortiderm




Cortiderm may be available in the countries listed below.


Ingredient matches for Cortiderm



Hydrocortisone

Hydrocortisone is reported as an ingredient of Cortiderm in the following countries:


  • Oman

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Cortiderm in the following countries:


  • Bahrain

International Drug Name Search

Cetirizine NeoCare




Cetirizine NeoCare may be available in the countries listed below.


Ingredient matches for Cetirizine NeoCare



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizine NeoCare in the following countries:


  • Netherlands

International Drug Name Search

Saturday 19 March 2011

Miokarpin




Miokarpin may be available in the countries listed below.


Ingredient matches for Miokarpin



Pilocarpine

Pilocarpine hydrochloride (a derivative of Pilocarpine) is reported as an ingredient of Miokarpin in the following countries:


  • Serbia

International Drug Name Search

Friday 18 March 2011

Nifedipin Basics




Nifedipin Basics may be available in the countries listed below.


Ingredient matches for Nifedipin Basics



Nifedipine

Nifedipine is reported as an ingredient of Nifedipin Basics in the following countries:


  • Germany

International Drug Name Search

Tuesday 15 March 2011

Marplan


Marplan is a brand name of isocarboxazid, approved by the FDA in the following formulation(s):


MARPLAN (isocarboxazid - tablet; oral)



  • Manufacturer: VALIDUS PHARMS INC

    Approved Prior to Jan 1, 1982

    Strength(s): 10MG [RLD]

Has a generic version of Marplan been approved?


No. There is currently no therapeutically equivalent version of Marplan available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Marplan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Marplan.

See also...

  • Marplan Consumer Information (Wolters Kluwer)
  • Marplan Consumer Information (Cerner Multum)
  • Marplan Advanced Consumer Information (Micromedex)
  • Isocarboxazid Consumer Information (Wolters Kluwer)
  • Isocarboxazid Consumer Information (Cerner Multum)
  • Isocarboxazid Advanced Consumer Information (Micromedex)

Sunday 13 March 2011

Risdon




Risdon may be available in the countries listed below.


Ingredient matches for Risdon



Risperidone

Risperidone is reported as an ingredient of Risdon in the following countries:


  • Taiwan

International Drug Name Search

Saturday 12 March 2011

Coraspir




Coraspir may be available in the countries listed below.


Ingredient matches for Coraspir



Aspirin

Acetylsalicylic Acid lysine (a derivative of Acetylsalicylic Acid) is reported as an ingredient of Coraspir in the following countries:


  • Mexico

International Drug Name Search

Flubiclox




Flubiclox may be available in the countries listed below.


Ingredient matches for Flubiclox



Flucloxacillin

Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Flubiclox in the following countries:


  • Australia

International Drug Name Search

Friday 11 March 2011

Climara


Climara is a brand name of estradiol, approved by the FDA in the following formulation(s):


CLIMARA (estradiol - film, extended release; transdermal)



  • Manufacturer: BAYER HLTHCARE

    Approval date: December 22, 1994

    Strength(s): 0.05MG/24HR [AB2], 0.1MG/24HR [RLD][AB2]


  • Manufacturer: BAYER HLTHCARE

    Approval date: March 23, 1998

    Strength(s): 0.075MG/24HR [AB2]


  • Manufacturer: BAYER HLTHCARE

    Approval date: March 5, 1999

    Strength(s): 0.025MG/24HR [AB2]


  • Manufacturer: BAYER HLTHCARE

    Approval date: May 27, 2003

    Strength(s): 0.0375MG/24HR [AB], 0.06MG/24HR [AB]

Has a generic version of Climara been approved?


Yes. The following products are equivalent to Climara:


estradiol film, extended release; transdermal



  • Manufacturer: MYLAN TECHNOLOGIES

    Approval date: February 24, 2000

    Strength(s): 0.05MG/24HR [AB2], 0.1MG/24HR [AB2]


  • Manufacturer: MYLAN TECHNOLOGIES

    Approval date: January 26, 2005

    Strength(s): 0.025MG/24HR [AB2], 0.075MG/24HR [AB2]


  • Manufacturer: MYLAN TECHNOLOGIES

    Approval date: July 20, 2006

    Strength(s): 0.0375MG/24HR [AB], 0.06MG/24HR [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Climara. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Climara.

See also...

  • Climara Consumer Information (Drugs.com)
  • Climara Weekly Patch Consumer Information (Wolters Kluwer)
  • Climara Consumer Information (Cerner Multum)
  • Estradiol Consumer Information (Drugs.com)
  • Estradiol Consumer Information (Wolters Kluwer)
  • Estradiol Acetate Consumer Information (Wolters Kluwer)
  • Estradiol Cypionate Consumer Information (Wolters Kluwer)
  • Estradiol Gel Consumer Information (Wolters Kluwer)
  • Estradiol Gel Packets Consumer Information (Wolters Kluwer)
  • Estradiol Patch Consumer Information (Wolters Kluwer)
  • Estradiol Ring Consumer Information (Wolters Kluwer)
  • Estradiol Spray Consumer Information (Wolters Kluwer)
  • Estradiol Valerate Consumer Information (Wolters Kluwer)
  • Estradiol Weekly Patch Consumer Information (Wolters Kluwer)
  • Estring Ring Consumer Information (Wolters Kluwer)
  • Estradiol injection Consumer Information (Cerner Multum)
  • Estradiol oral Consumer Information (Cerner Multum)
  • Estradiol topical for use on skin Consumer Information (Cerner Multum)
  • Estradiol transdermal Consumer Information (Cerner Multum)
  • Estradiol vaginal Consumer Information (Cerner Multum)
  • Estradiol AHFS DI Monographs (ASHP)

Condylin




Condylin may be available in the countries listed below.


Ingredient matches for Condylin



Podophyllotoxin

Podophyllotoxin is reported as an ingredient of Condylin in the following countries:


  • Bulgaria

International Drug Name Search

Thursday 10 March 2011

Bellisin




Bellisin may be available in the countries listed below.


Ingredient matches for Bellisin



Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Bellisin in the following countries:


  • Ireland

International Drug Name Search

Tuesday 1 March 2011

Metformina Bexal




Metformina Bexal may be available in the countries listed below.


Ingredient matches for Metformina Bexal



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformina Bexal in the following countries:


  • Spain

International Drug Name Search